Cayman Chemical
Data updated
Enterprise Intelligence
Quarterly psychedelic drug-development briefing
Compare indication activity, programme milestones, competitive intensity, and near-term catalysts. Q2 includes quarter-over-quarter changes against the published Q1 baseline.
Cayman Chemical is a US biochemical supplier and manufacturer based in Ann Arbor, Michigan, founded in 1980. Through its own operations and its Cayman Pharma cGMP API platform it provides research biochemicals, reference materials and cGMP active pharmaceutical ingredients, including psychedelic compounds supplied for analytical work and clinical-trial pathways.
Manufacturing Snapshot
Established CDMO / ManufacturerScope & Capabilities
Supply Use Cases
GxP / Compliance
Facilities & Access
Combined US and Czech manufacturing footprint via Cayman Chemical and Cayman Pharma.
Capacity Notes
API manufacturing materials describe annual capacity plus scale-up capability for multi-step synthesis programs.
Supported Substances
Cayman API materials cite cGMP psilocybin and psilocin for clinical trials, with development listings including 3,4-MDMA and N,N-DMT.
Quick Facts
- Founded
- 1980
- HQ
- United States
- Website
- Visit